Aurobindo Pharma Ltd Half Yearly Results

Gross Sales

16,274.27

15,103.86

14,763.15

13,941.35

12,766.64

Excise Duty

0

0

0

0

0

Net Sales

16,274.27

15,103.86

14,763.15

13,941.35

12,766.64

Other Operating Income

86.37

259.23

168.78

128.59

113.45

Other Income

264.92

356.93

283.86

273.52

192.78

Total Income

16,625.56

15,720.02

15,215.79

14,343.46

13,072.87

Total Expenditure

12,994.16

12,178.47

11,780.89

11,587

10,895.19

PBIDT

3,631.4

3,541.55

3,434.9

2,756.46

2,177.68

Interest

233.5

223.74

164.98

124.73

100.56

PBDT

3,397.9

3,317.81

3,269.92

2,631.73

2,077.12

Depreciation

862.96

786.46

777.6

744.06

666.97

Minority Interest Before NP

0

0

0

0

0

Tax

928.58

771.4

955.24

822.3

716.46

Deferred Tax

-142.04

24.78

-310.24

-256.28

-303.21

Reported Profit After Tax

1,748.4

1,735.17

1,847.32

1,321.65

996.9

Minority Interest After NP

-0.88

-1.43

2.28

-6.28

-0.61

Net Profit after Minority Interest

1,749.28

1,736.6

1,845.04

1,327.93

997.51

Extra-ordinary Items

0

0

-122.11

-39.37

0

Adjusted Profit After Extra-ordinary item

1,749.28

1,736.6

1,967.15

1,367.3

997.51

EPS (Unit Curr.)

30.12

29.69

31.49

22.57

17.03

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

58.08

58.08

58.59

58.59

58.59

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

22.31

23.44

23.26

19.77

17.05

PBDTM(%)

-

-

-

-

-

PATM(%)

10.74

11.48

12.51

9.48

7.8